SYN-004 (ribaxamase), an Oral Beta-Lactamase, Mitigates Antibiotic-
Mediated Dysbiosis in a Porcine Gut Microbiome Model, Journal of Applied
Enrichment dynamics of Listeria monocytogenes and the
associated microbiome from naturally contaminated ice cream linked to a
listeriosis outbreak, BMC Microbiology, 2016.
Development of SYN-004, an oral beta-lactamase treatment to protect the
gut microbiome from antibiotic-mediated damage and prevent Clostridium
difficile infection, Anaerobe, 2016.
Cross-talk among flesh-eating Aeromonas hydrophila strains in mixed
infection leading to necrotizing fasciitis, PNAS, 2015.
Longitudinal analysis of microbial interaction between humans and the
indoor environment, Science, 2014.
Microbial Community Profiling of Human Saliva Using Shotgun
Metagenomic Sequencing, PLOS One, 2014